VanEck Pharmaceutical ETF
PPH
NASDAQ
| Weiss Ratings | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $110.12 | |||
| Company Info | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | VanEck | |||
| Manager/Tenure (Years) | Peter H. Liao (14), Griffin Driscoll (2) | |||
| Website | http://www.vaneck.com | |||
| Phone Number | 800-826-1115 | |||
| Fund Information | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | VanEck Pharmaceutical ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 20, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.92% | |||
| Dividend | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.60% | |||
| Asset Allocation | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.00% | |||
| Stock | 100.00% | |||
| U.S. Stock | 63.60% | |||
| Non-U.S. Stock | 36.40% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.95% | |||
| 30-Day Total Return | 1.37% | |||
| 60-Day Total Return | -1.21% | |||
| 90-Day Total Return | 5.45% | |||
| Year to Date Total Return | 8.24% | |||
| 1-Year Total Return | 25.72% | |||
| 2-Year Total Return | 16.09% | |||
| 3-Year Total Return | 42.21% | |||
| 5-Year Total Return | 57.98% | |||
| Price | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $115.52 | |||
| 1-Month Low Price | $108.15 | |||
| 1-Month High Price | $117.87 | |||
| 52-Week Low Price | $85.99 | |||
| 52-Week Low Price (Date) | Sep 25, 2025 | |||
| 52-Week High Price | $117.87 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| NAV | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $108.08 | |||
| 1-Month High NAV | $117.86 | |||
| 52-Week Low NAV | $85.97 | |||
| 52-Week Low NAV (Date) | Sep 25, 2025 | |||
| 52-Week High NAV | $117.86 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| Beta / Standard Deviation | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.43 | |||
| Standard Deviation | 13.81 | |||
| Balance Sheet | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.03B | |||
| Operating Ratios | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.36% | |||
| Turnover Ratio | 30.00% | |||
| Performance | PPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 26.49% | |||
| Last Bear Market Total Return | -3.06% | |||